June is Men’s Health Month, so it seems appropriate to begin the month by focusing on a topic specific to men’s wellness and ...
Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept ...
OverviewThe global urology surgical instruments market is set to experience steady growth, with an anticipated compound ...
PSMA PET has become central to prostate cancer imaging as advanced disease incidence rises and prostate-specific membrane ...
A new UCL-led international trial will assess whether AI can perform as well as expert radiologists at detecting prostate ...
Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing ...
The largest real-world study ever conducted on prostate cancer in Brazil analyzed data from 670,205 patients treated through ...
The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...
Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, prostate cancer often comes with traditional treatments that cause difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results